Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:06 PM
Study NCT ID:
NCT04685135
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-22
First Post:
2020-12-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-21
First Submit QC Date:
None
Study First Post Date:
2020-12-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-20
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-20
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL